trending Market Intelligence /marketintelligence/en/news-insights/trending/SigwKEgl2ege2eiERfNaVw2 content esgSubNav
In This List

Pfizer to sell Colo. facility to CordenPharma

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Pfizer to sell Colo. facility to CordenPharma

Pfizer Inc. is selling its former Hospira Boulder active pharmaceutical ingredients site in Colorado to CordenPharma, a contract development and manufacturing organization.

CordenPharma will also enter into a multiyear supply arrangement with Pfizer.

Hospira Boulder will change its name to CordenPharma Boulder and will be managed by Brian McCudden, CEO of CordenPharma Colorado.

The transaction is expected to close in November.